REFILE-UPDATE 1-Merck's Keytruda succeeds in late-stage lung cancer study
May 23, 2018 at 07:26 AM EDT
May 23 (Reuters) - Merck & Co on Wednesday said its cancer drug Keytruda helped extend survival and prevented disease progression when tested in a late-stage study in combination with chemotherapy for a type of lung cancer.